Government Employees Health Association v. Actelion Pharmaceuticals Ltd. et al, No. 1:2018cv03560 - Document 213 (D. Md. 2023)
Court Description: MEMORANDUM OPINION AND ORDER Denying 206 Motion for Leave to File Sur-Reply in Opposition to Plaintiff's Motion for Spoliation-Related Sanctions, filed by Janssen Research & Development, LLC, Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc. ; denying 206 Motion for Leave to File. Signed by Magistrate Judge J. Mark Coulson on 1/13/2023. (bas, Deputy Clerk)
Download PDF
<![CDATA[
Government Employees Health Association v. Actelion Pharmaceuticals Ltd. et al Doc. 213 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND * * GOVERNMENT EMPLOYEES HEALTH ASSOCIATION, on behalf of itself and all others similarly situated, * * Plaintiff, v. * Civil Case No: 1:18-cv-03560-GLR ACTELION PHARMACEUTICALS LTD., et al., * Defendants. * * * * * * * * * * * * MEMORANDUM OPINION AND ORDER Defendants’ Motion for Leave to File Sur-Reply (ECF No. 206) is DENIED. In reviewing Plaintiff’s original reply (ECF No. 203), the Court concludes that it does not raise new arguments that would, in turn, support allowing Defendants a sur-reply so as to rebut such arguments. Furthermore, in its own review of the proposed sur-reply as it evaluated Defendants’ request, the Court did not uncover any information or arguments that it had not already considered as it prepares for the motions hearing scheduled for January 17, 2023. That said, Defendants are not precluded from incorporating the matters raised in their proposed sur-reply into any arguments they wish to present at that motions hearing. Date: January 13, 2022 /s/ __ J. Mark Coulson United States Magistrate Judge Dockets.Justia.com
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
